Autopsy report · NCT03566303

Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis

“Coronavirus Pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 10 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Hospital Geral Roberto Santos

Sponsor type

University, hospital or other

Conditions

Prostheses and Implants; Stroke; Valve Heart Disease; Anticoagulants and Bleeding Disorders

Interventions

Rivaroxaban 15 mg; Warfarin

Participants

50

Sites

1

Countries

Brazil

Trials that died the same way

• Brief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain.
  “Corona pandemic” (82% match in meaning)
• Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
  “COVID pandemic” (81% match in meaning)
• Validation of Cognitive Screenings for the Hearing Impaired
  “The corona virus pandemic\_UK national lockdown” (76% match in meaning)
• Efficacy of Aspirin and L-arginine in High Risk Preeclamptic
  “COVID-19 pandemic” (75% match in meaning)
• Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
  “Due to the Coronavirus Disease 2019 (COVID-19) pandemic” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.